Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-134-8 | CAS number: 60270-33-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.96 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 74 mg/m³
- Explanation for the modification of the dose descriptor starting point:
results in lowest DNEL; for discussion, please see below
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator)
- AF for differences in duration of exposure:
- 2
- Justification:
- Default (DNEL calculator)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (DNEL calculator)
- AF for other interspecies differences:
- 1
- Justification:
- The substance is expected to be metabolised via general metabolic pathways that are common and very similar to rodents and humans and the absence of any specific target organs indicating a specific MOA at high concentrations there is no reason to believe that an additional AF of 2.5 for remaining differences is justified.
- AF for intraspecies differences:
- 5
- Justification:
- Default (DNEL calculator)
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 420 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
results in lowest DNEL; for discussion, please see below
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator)
- AF for differences in duration of exposure:
- 2
- Justification:
- Default (DNEL calculator)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 5
- Justification:
- Default (DNEL calculator)
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Route-to-route extrapolation:
Oral absorption
DIMAPDO has a molecular weight < 500 g/mol and a log Kow between -1 and 4 which is in general favourable for absorption. The estimated pka (Base) of 9.2 ± 0.4 means that the substance will be present almost completely ionised in the stomach (pH 2) and below 10% unionised in the small intestine (pH 8) which is disadvantageous for the diffusion across the biological membranes in the gastro-intestinal tract. In general solids with a microscale particle diameter are too large to be directly taken up by pinocytosis and have to be dissolved before they can be absorbed. DIMAPDO has a very low water solubility below 0.1 mg/L and forms micelles in aqueous solutions (CMC = 0.009 g/L) which will additionally limit the absorption rate.
Therefore, an estimated absorption rate of 50 % may be appropriate for DIMAPDO.
Dermal absorption
Based on above data the substance may be absorbed dermally. The molecular weight < 500 g/mol, a log Kow between -1 and 4 favour a dermal absorption. Taking in account the pKa of 9.2 ± 0.4 meaning at skin pH of 5.5 almost all DIMAPDO molecules will be ionised and the very low water solubility < 0.1 mg/L a high dermal absorption is nevertheless unlikely. This is supported by a dermal absorption calculation using the IH SkinPerm model (v1.21). The absorbed fractions have been estimated to be 0% after 8 and 24 h and the absorbed amounts 0.12 and 0.35 mg after 8 and 24 h, respectively. The maximum dermal absorption rate has been calculated to be 3.60E-06 mg/cm²/h. Due to missing information about the applicability of the calculation model in respect to the substance under investigation the results should be treated with care.
Therefore, for exposure assessments a value of 10 % of absorption after dermal exposure may be appropriate.
Inhalation absorption
DIMAPDO is solid at room temperature and has a very high boiling point (> 300°C) together with a low vapour pressure (7.1E-009 Pa) therefore substance evaporation and uptake by inhalation as vapour is unlikely.
The uptake after direct inhalation of substance dust particles and aerosols is also very unlikely because DIMAPDO is marketed and used in a granular form (flakes) or as waxy liquid.
Nonetheless for chemical safety assessment an inhalation absorption rate of 100% is assumed as a worst case default value in the absence of other data.
DNELs derived from the oral subacute study NOAEL (OECD guideline 408; source substance Coco amidopropyldimethylamine)
There were no mortalities or relevant clinical signs. Body weights, body weight gains and food consumption were unaffected. There were no adverse changes on ophthalmological, haematological or clinical chemistry parameters and no macroscopic changes or organ weight changes observed at gross necropsy. Histopathological examination revealed the presence of local proliferative lesions in the forestomach in all treatment groups, with an increasing incidence and severity. The lesions were characterized by areas of a thickened epithelial layer, frequently accompanied by hyperkeratosis and undulations at the basement membrane zone. Undulations are believed to be caused by the space occupying expansion of the epithelial layer of the forestomach and considered a secondary change. Signs of slight cellular atypia were noted in few males treated with 30 mg/kg/day bw/day and in a male and female treated with 60 mg/kg bw/day. The finding of obvious squamous cell hyperplasia (with early signs of atypia in some cases) in the non-glandular stomach of rats treated with 30 or 60 mg/kg bw/day is considered an adverse finding. Lesion in the non-glandular stomach of rodents however are considered clinically irrelevant since humans do not have a forestomach equivalent.
As no signs of systemic toxicity were observed, the NOAEL for systemic toxicity is 60 mg/kg bw, the highest dose tested in this study.
Hazard conclusions for workers based on the NOAEL of 60 mg/kg bw/d for general toxicity
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 2.96mg/m³ |
repeated dose toxicity (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 4.2mg/kg bw/day |
repeated dose toxicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:25
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:2 (Default (DNEL calculator))
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:100
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:2 (Default (DNEL calculator))
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
DNELs derived from reproduction/developmental NOAEL (OECD guideline 421; source substance Stearic acid 3-(dimethylaminopropyl)amide)
The NOAEL for general toxicity was 70 mg/kg bw/d based on effects on body weight and food consumption at 200 mg/kg bw/d.
For fertility, individual NOAELs for males and females have been identified:
In females, lower numbers of implantation sites (in the presence of maternal toxicity) have been noted in a reproduction/developmental screening study at 200 mg/kg bw/d. Thus, the NOAEL for female fertility in that study was 70 mg/kg bw/d. For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).
The NOAEL(fertility males) was 200 mg/kg bw/d (highest dose administered) based on no specific findings on reproductive organs and normal spermatogenic staging profiles for males examined (control and high dose males). For male fertility an additional assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.
Hazard conclusions for workers based on the NOAEL of 70 mg/kg bw/d for female fertility effects
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 5.92mg/m³ |
repeated dose toxicity (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 8.4mg/kg bw/day |
repeated dose toxicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Default (DNEL calculator)
Overall Assessment Factor:12.5
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Default (DNEL calculator)
Overall Assessment Factor:50
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Hazard conclusions for workers based on the NOAEL of 200 mg/kg bw/d for male fertility effects
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 6.58mg/m³ |
effect on fertility (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 9.33mg/kg bw/day |
effect on fertility (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:37.5
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:3 (For male fertility an assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:150
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:3 (For male fertility an assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
DNELs derived from reproduction/developmental NOAEL (OECD guideline 414; source substance Coco amidopropyldimethylamine)
Hazard conclusions for workers based on the NOAEL of 100 mg/kg bw/d
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term
|
DNEL (Derived No Effect Level) 9.87mg/m³
|
developmental toxicity / teratogenicity (Oral) |
Dermal
|
Systemic effects - Long-term
|
DNEL (Derived No Effect Level) 14mg/kg bw/day
|
developmental toxicity / teratogenicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:12.5
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (No time extrapolation required, since the suceptible window is fully covered.)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:50
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (No time extrapolation required, since the suceptible window is fully covered.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:5 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Conclusion
The DNELs of the subchronic repeated-dose toxicity study (OECD 408) are also protective for male and female fertility and development.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.522 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 26.1 mg/m³
- Explanation for the modification of the dose descriptor starting point:
results in lowest DNEL; for discussion, please see below
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator)
- AF for differences in duration of exposure:
- 2
- Justification:
- Default (DNEL calculator)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (DNEL calculator)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator)
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
results in lowest DNEL; for discussion, please see below
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator)
- AF for differences in duration of exposure:
- 2
- Justification:
- Default (DNEL calculator)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator)
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.3 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 60 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
results in lowest DNEL
- AF for dose response relationship:
- 1
- Justification:
- Default (DNEL calculator)
- AF for differences in duration of exposure:
- 2
- Justification:
- Default (DNEL calculator)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default (DNEL calculator)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default (DNEL calculator)
- AF for intraspecies differences:
- 10
- Justification:
- Default (DNEL calculator)
- AF for the quality of the whole database:
- 1
- Justification:
- Default (DNEL calculator)
- AF for remaining uncertainties:
- 1
- Justification:
- no remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
oute-to-route extrapolation:
Oral absorption
DIMAPDO has a molecular weight < 500 g/mol and a log Kow between -1 and 4 which is in general favourable for absorption. The estimated pka (Base) of 9.2 ± 0.4 means that the substance will be present almost completely ionised in the stomach (pH 2) and below 10% unionised in the small intestine (pH 8) which is disadvantageous for the diffusion across the biological membranes in the gastro-intestinal tract. In general solids with a microscale particle diameter are too large to be directly taken up by pinocytosis and have to be dissolved before they can be absorbed. DIMAPDO has a very low water solubility below 0.1 mg/L and forms micelles in aqueous solutions (CMC = 0.009 g/L) which will additionally limit the absorption rate.
Therefore, an estimated absorption rate of 50 % may be appropriate for DIMAPDO.
Dermal absorption
Based on above data the substance may be absorbed dermally. The molecular weight < 500 g/mol, a log Kow between -1 and 4 favour a dermal absorption. Taking in account the pKa of 9.2 ± 0.4 meaning at skin pH of 5.5 almost all DIMAPDO molecules will be ionised and the very low water solubility < 0.1 mg/L a high dermal absorption is nevertheless unlikely. This is supported by a dermal absorption calculation using the IH SkinPerm model (v1.21). The absorbed fractions have been estimated to be 0% after 8 and 24 h and the absorbed amounts 0.12 and 0.35 mg after 8 and 24 h, respectively. The maximum dermal absorption rate has been calculated to be 3.60E-06 mg/cm²/h. Due to missing information about the applicability of the calculation model in respect to the substance under investigation the results should be treated with care.
Therefore, for exposure assessments a value of 10 % of absorption after dermal exposure may be appropriate.
Inhalation absorption
DIMAPDO is solid at room temperature and has a very high boiling point (> 300°C) together with a low vapour pressure (7.1E-009 Pa) therefore substance evaporation and uptake by inhalation as vapour is unlikely.
The uptake after direct inhalation of substance dust particles and aerosols is also very unlikely because DIMAPDO is marketed and used in a granular form (flakes) or as waxy liquid.
Nonetheless for chemical safety assessment an inhalation absorption rate of 100% is assumed as a worst case default value in the absence of other data.
DNELs derived from the oral subacute study NOAEL (OECD guideline 408; source substance Coco amidopropyldimethylamine)
There were no mortalities or relevant clinical signs. Body weights, body weight gains and food consumption were unaffected. There were no adverse changes on ophthalmological, haematological or clinical chemistry parameters and no macroscopic changes or organ weight changes observed at gross necropsy. Histopathological examination revealed the presence of local proliferative lesions in the forestomach in all treatment groups, with an increasing incidence and severity. The lesions were characterized by areas of a thickened epithelial layer, frequently accompanied by hyperkeratosis and undulations at the basement membrane zone. Undulations are believed to be caused by the space occupying expansion of the epithelial layer of the forestomach and considered a secondary change. Signs of slight cellular atypia were noted in few males treated with 30 mg/kg/day bw/day and in a male and female treated with 60 mg/kg bw/day. The finding of obvious squamous cell hyperplasia (with early signs of atypia in some cases) in the non-glandular stomach of rats treated with 30 or 60 mg/kg bw/day is considered an adverse finding. Lesion in the non-glandular stomach of rodents however are considered clinically irrelevant since humans do not have a forestomach equivalent.
As no signs of systemic toxicity were observed, the NOAEL for systemic toxicity is 60 mg/kg bw, the highest dose tested in this study.
Hazard conclusions for general population based on the NOAEL of 60 mg/kg bw/d for general toxicity
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 0.522mg/m³ |
repeated dose toxicity (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 1.5mg/kg bw/day |
repeated dose toxicity (Oral) |
Oral
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 0.3mg/kg bw/day |
repeated dose toxicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:50
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:2 (Default (DNEL calculator))
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:200
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:2 (Default (DNEL calculator))
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Oral Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:200
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:2 (Default (DNEL calculator))
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
DNELs derived from reproduction/developmental NOAEL (OECD guideline 421; source substance Stearic acid 3-(dimethylaminopropyl)amide)
The NOAEL for general toxicity was 70 mg/kg bw/d based on effects on body weight and food consumption at 200 mg/kg bw/d.
For fertility, individual NOAELs for males and females have been identified:
In females, lower numbers of implantation sites (in the presence of maternal toxicity) have been noted in a reproduction/developmental screening study at 200 mg/kg bw/d. Thus, the NOAEL for female fertility in that study was 70 mg/kg bw/d. For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).
The NOAEL(fertility males) was 200 mg/kg bw/d (highest dose administered) based on no specific findings on reproductive organs and normal spermatogenic staging profiles for males examined (control and high dose males). For male fertility an additional assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.
Hazard conclusions for general population based on the NOAEL of 70 mg/kg bw/d for female fertility effects
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 1.04mg/m³ |
repeated dose toxicity (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 3mg/kg bw/day |
repeated dose toxicity (Oral) |
Oral
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 0.6mg/kg bw/day |
repeated dose toxicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Default (DNEL calculator)
Overall Assessment Factor:25
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Default (DNEL calculator)
Overall Assessment Factor:100
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Oral Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Default (DNEL calculator)
Overall Assessment Factor:100
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (For female fertility effects no assessment factor for time extrapolation was applied as the exposure regime in the screening study is similar to that in the definitive test (1-generation study) (from which no time extrapolation would be required) – 14 d exposure prior to mating, during pregnancy, lactation, up to weaning (the latter is not relevant in the screening test).)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Hazard conclusions for general population based on the NOAEL of 200 mg/kg bw/d for male fertility effects
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 1.16mg/m³ |
effect on fertility (Oral) |
Dermal
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 3.33mg/kg bw/day |
effect on fertility (Oral) |
Oral
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 0.667mg/kg bw/day |
effect on fertility (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:75
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:3 (For male fertility an assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:300
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:3 (For male fertility an assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Oral Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:300
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:3 (For male fertility an assessment factor for time extrapolation is required, as the exposure regime is different in the screening study (starting at 14 d prior to mating) and the definitive test (starting at 70 d prior to mating). As stated in the REACH TGD, time extrapolation from a subacute to subchronic study is required (AF 3). The extrapolation is from the screening test to the definitive test, which is not a chronic, but a subchronic study.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
DNELs derived from reproduction/developmental NOAEL (OECD guideline 414; source substance Coco amidopropyldimethylamine)
Hazard conclusions for general population based on the NOAEL of 100 mg/kg bw/d
Route |
Type of effect |
Hazard conclusion |
Most sensitive endpoint |
Inhalation
|
Systemic effects - Long-term |
DNEL (Derived No Effect Level) 1.74mg/m³ |
developmental toxicity / teratogenicity (Oral) |
Dermal
|
Systemic effects - Long-term
|
DNEL (Derived No Effect Level) 5mg/kg bw/day
|
developmental toxicity / teratogenicity (Oral) |
Oral
|
Systemic effects - Long-term
|
DNEL (Derived No Effect Level) 1mg/kg bw/day
|
developmental toxicity / teratogenicity (Oral) |
Inhalation Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEC
Overall Assessment Factor:25
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (No time extrapolation required, since the suceptible window is fully covered.)
AF for interspecies differences (allometric scaling):1 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Dermal Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:100
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (No time extrapolation required, since the suceptible window is fully covered.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Oral Systemic effects - Long-term
DNEL derivation method:
Dose descriptor starting point:NOAEL
Modified dose descriptor starting point:NOAEL
Overall Assessment Factor:100
AF for dose response relationship:1 (Default (DNEL calculator))
AF for difference in duration of exposure:1 (No time extrapolation required, since the suceptible window is fully covered.)
AF for interspecies differences (allometric scaling):4 (Default (DNEL calculator))
AF for other interspecies differences:2.5 (Default (DNEL calculator))
AF for intraspecies differences:10 (Default (DNEL calculator))
AF for the quality of the whole database:1 (Default (DNEL calculator))
Conclusion
The DNELs of the subchronic repeated-dose toxicity study (OECD 408) are also protective for male and female fertility and development.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.